Wayne P. Rothbaum is Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA). They have made 5 open-market trades across 1 company since 2018, most recently 2024-02-20.
CIK 0001423102
5 open-market purchases totalling $165.8M since 2018, never a sale. Across 5 scored buys the stock is up 13.9% at ninety days, and 11.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IOVA | 28,067,333 | $382.8M |
Shares reported on the most recent Form 4, priced at the 2024-02-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 60% |
| Avg Move | +1.0% | +6.1% | +13.9% |
| Alpha | +4.1% | +8.6% | +11.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IOVA | BUY | 2024-02-20 | 2024-02-20 | $9.15 | $45.8M | +38.8% | +26.9% | -14.5% |
| IOVA | BUY | 2023-09-15 | 2023-09-15 | $5.30 | $26.5M | -19.4% | -36.0% | +38.2% |
| IOVA | BUY | 2022-12-02 | 2022-12-02 | $6.50 | $65.0M | -18.2% | -25.8% | -13.6% |
| IOVA | BUY | 2022-05-31 | 2022-06-02 | $6.60 | $6.6M | +10.7% | +65.8% | +53.6% |
| IOVA | BUY | 2018-12-04 | 2018-12-07 | $10.25 | $22.0M | -7.1% | -0.5% | +6.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.